On December 29, 2023, Scinai Immunotherapeutics Ltd. entered into agreements allowing warrant holders to exercise 2,606,552 American Depositary Shares at a reduced price of $0.65 each, expecting to raise approximately $1.69 million for general corporate purposes. The closing of the transaction is anticipated around January 3, 2024.